Metaplastic breast carcinoma
MONDO:0006043A group of invasive breast carcinomas characterized by the presence of an adenocarcinomatous component which is admixed with a dominant component that is composed of squamous cells, spindle cells, or mesenchymal cells.
Also known as: metaplastic breast carcinoma, metaplastic carcinoma of breast, metaplastic carcinoma of the breast, breast metaplastic carcinoma, metaplastic breast cancer
2800 clinical trials for this condition and its sub-types, 4 tagged with Metaplastic breast carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Metaplastic breast carcinoma
-
Squamous cell breast carcinoma 0 trials
4 sub-types
-
Immunotherapy duo takes on rare tumors
Disease control OngoingThis phase 2 trial is testing a combination of two immunotherapy drugs, nivolumab and ipilimumab, in 798 people with over 50 types of rare cancers. The goal is to see if these drugs can shrink tumors by helping the immune system attack cancer cells. Participants receive the drugs…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New combo therapy targets tough breast cancers in early trial
Disease control OngoingThis study tests a new drug (MEN1611) combined with chemotherapy (eribulin) for people with advanced breast cancer that has specific genetic changes (PIK3CA/PTEN). The goal is to see if the combination can shrink tumors or stop them from growing. About 14 participants will receiv…
Phase 2 • Sponsor: MedSIR • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC